New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns

Study on the bioRxiv server reports that the SARS-CoV-2 KP.2 variant, despite lower infectivity, shows significant immune resistance and higher transmissibility compared to other variants, potentially impacting global public health and vaccine efficacy.

The Women’s Health Initiative continues to provide a wealth of nutrition insights

The Women’s Health Initiative (WHI), a landmark study among 161,808 postmenopausal women that has been ongoing for more than 40 years, continues to contribute a

October 18, 2024

Cell and gene therapies could be a safer bet than other drugs

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

October 12, 2023

Theratechnologies hit with FDA refusal to file letter for intramuscular version of HIV drug

Theratechnologies was hit with a second setback from the FDA this year as the agency handed down a refusal to file letter for the company’s

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.